Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.

Bai, Bing; Huang, Hui-Qiang; Cai, Qing-Qing; Wang, Xiao-Xiao; Cai, Qi-Chun; Lin, Ze-Xiao; Gao, Yan; Xia, Yi; Bu, Qing; Guo, Ying

Bai, Bing; Huang, Hui-Qiang; Cai, Qing-Qing; Wang, Xiao-Xiao; Cai, Qi-Chun; Lin, Ze-Xiao; Gao, Yan; Xia, Yi; Bu, Qing; Guo, Ying.

Affiliation

Bai B; Department of Medical Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou 510060, Guangdong, People's Republic of China.

Med Oncol ; 30(1): 350, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23329307

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Hodgkin Disease/drug therapy; Lymphoma, Non-Hodgkin/drug therapy; Salvage Therapy/methods; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Female; Hodgkin Disease/mortality; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin/mortality; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Time; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/adverse effects; Vinblastine/analogs & derivatives; Vinorelbine; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Med Oncol Journal subject: NEOPLASIAS Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google